The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
HMGB1 as a therapeutic target in disease
Open accessAbstract
High‐mobility group box 1 (HMGB1) was initially recognized as a ubiquitous nuclear protein involved in maintaining the nucleosome integrity and facilitating gene transcription. HMGB1 has since been reevaluated to be a prototypical damage‐associated molecular pattern (DAMP) protein, and together with its exogenous counterpart, pathogen‐associated molecular pattern (PAMP), completes the body's alarmin system against disturbances in homeostasis. HMGB1 can be released into the extracellular matrix (ECM) by either granulocytes or necrotic cells to serve as a chemotaxis/cytokine during infection, endotoxemia, hypoxia, ischemia–reperfusion events, and cancer. Different isoforms of HMGB1 present with distinctive physiological functions in ECM—fully‐reduced HMGB1 (all thiol) acts as the initial damage signal to recruit circulating myeloid cells, disulfide HMGB1 behaves as a cytokine to activate macrophages and neutrophils, and both signals are turned off when HMGB1 is terminally oxidized into the final sulfonate form. Targeting HMGB1 constitutes a favorable therapeutic strategy for inflammation and inflammatory diseases. Antagonists such as ethyl pyruvate inhibit HMGB1 by interfering with its cytoplasmic exportation, while others such as glycyrrhizin directly bind to HMGB1 and render it unavailable for its receptors. The fact that a mixture of different HMGB1 isoforms is present in the ECM poses a challenge in pinpointing the exact role of an individual antagonist. A more discriminative probe for HMGB1 may be necessary to advance our knowledge of HMGB1, HMGB1 antagonists, and inflammatory‐related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Su, Z., Zhang, P., Yu, Y., Lu, H., Liu, Y., Ni, P., Su, X., Wang, D., Liu, Y., Wang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep21884 · Cited by 83
RetractedRelease of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 1×
“HMGB1 knockout (KO) cells are unable to activate monocytes during necrosis, thereby delaying the start of the inflammatory response (Scaffidi et al., 2002).”
BackgroundHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Self-citationYang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Self-citationHigh-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Self-citationThe nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Self-citationEndogenous HMGB1 regulates autophagy
Tang, D., Kang, R., Livesey, K. M., Cheh, C.-W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M. E., Tracey, K. J., Zeh, H. J., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911078 · Cited by 951
Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., & Rubartelli, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf198 · Cited by 926
HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832
Self-citationYang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 809
Self-citationCD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786 · cited 1×
“HMGB1, Siglec‐10, and CD24 seem to form a trimer and regulate acetaminophen‐induced inflammation through the NF‐κB pathway (G. Y. Chen et al., 2009).”
BackgroundHMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120189 · Cited by 720 · cited 2×
“When these three cysteines are replaced with nonoxidizable, polarity‐similar serine residues (HMGB1‐3s), the resulting HMGB1 loses cytokine‐stimulating activity, but becomes more effective in recruiting leukocytes (Venereau et al., 2012).”
BackgroundMethodSelf-citationHMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
Harris, H. E., Andersson, U., & Pisetsky, D. S. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.222 · Cited by 689
Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111739 · Cited by 676
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., & Bianchi, M. E. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.03.007 · Cited by 612
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D., Yang, R., Czura, C. J., Fink, M. P., & Tracey, K. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192222999 · Cited by 585
Self-citationKim, J.-B., Sig Choi, J., Yu, Y.-M., Nam, K., Piao, C.-S., Kim, S.-W., Lee, M.-H., Han, P.-L., Park, J.-S., & Lee, J.-K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3815-05.2006 · Cited by 579
Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia
Lamkanfi, M., Sarkar, A., Vande Walle, L., Vitari, A. C., Amer, A. O., Wewers, M. D., Tracey, K. J., Kanneganti, T.-D., & Dixit, V. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000803 · Cited by 465
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
Muhammad, S., Barakat, W., Stoyanov, S., Murikinati, S., Yang, H., Tracey, K. J., Bendszus, M., Rossetti, G., Nawroth, P. P., Bierhaus, A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2435-08.2008 · Cited by 412
Self-citationMD-2 is required for disulfide HMGB1–dependent TLR4 signaling
Yang, H., Wang, H., Ju, Z., Ragab, A. A., Lundbäck, P., Long, W., Valdes-Ferrer, S. I., He, M., Pribis, J. P., Li, J., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141318 · Cited by 375
Self-citationJAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Lu, B., Antoine, D. J., Kwan, K., Lundbäck, P., Wähämaa, H., Schierbeck, H., Robinson, M., Van Zoelen, M. A. D., Yang, H., Li, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316925111 · Cited by 366
Self-citationLiu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8770com · Cited by 366
The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases
Magna, M., & Pisetsky, D. S. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00164 · Cited by 358
Kokkola, R., Li, J., Sundberg, E., Aveberger, A. ‐., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Self-citationYang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604008103 · Cited by 322
Self-citation(2002) · PubMed · Cited by 292
Yang, H., Rivera, Z., Jube, S., Nasu, M., Bertino, P., Goparaju, C., Franzoso, G., Lotze, M. T., Krausz, T., Pass, H. I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006542107 · Cited by 281
Self-citationBianchi, M. E., Falciola, L., Ferrari, S., & Lilley, D. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05144.x · Cited by 271
p53/HMGB1 Complexes Regulate Autophagy and Apoptosis
Livesey, K. M., Kang, R., Vernon, P., Buchser, W., Loughran, P., Watkins, S. C., Zhang, L., Manfredi, J. J., Zeh, H. J., Li, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2291 · Cited by 262
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Jube, S., Rivera, Z. S., Bianchi, M. E., Powers, A., Wang, E., Pagano, I., Pass, H. I., Gaudino, G., Carbone, M., & Yang, H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3481 · Cited by 255
Self-citationMerenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., & Rauvala, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55361-8 · Cited by 242
Kang, R., Tang, D., Schapiro, N. E., Loux, T., Livesey, K. M., Billiar, T. R., Wang, H., Van Houten, B., Lotze, M. T., & Zeh, H. J. (2014) · Oncogene · doi:10.1038/onc.2012.631 · Cited by 230
Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma
Carbone, M., & Yang, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2259 · Cited by 229
Self-citationPriming the nucleosome: a role for HMGB proteins?
Travers, A. A. (2003) · EMBO reports · doi:10.1038/sj.embor.embor741 · Cited by 214
HMGB1 and leukocyte migration during trauma and sterile inflammation
Venereau, E., Schiraldi, M., Uguccioni, M., & Bianchi, M. E. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.10.037 · Cited by 211
Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis
Maugeri, N., Capobianco, A., Rovere-Querini, P., Ramirez, G. A., Tombetti, E., Valle, P. D., Monno, A., D’Alberti, V., Gasparri, A. M., Franchini, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3089 · Cited by 211
Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice
Kang, R., Zhang, Q., Hou, W., Yan, Z., Chen, R., Bonaroti, J., Bansal, P., Billiar, T. R., Tsung, A., Wang, Q., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.015 · Cited by 209
Hayakawa, K., Pham, L.-D. D., Katusic, Z. S., Arai, K., & Lo, E. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121146109 · Cited by 187
Oh, Y. J., Youn, J. H., Ji, Y., Lee, S. E., Lim, K. J., Choi, J. E., & Shin, J.-S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801873 · Cited by 177
Critical role of RAGE and HMGB1 in inflammatory heart disease
Bangert, A., Andrassy, M., Müller, A.-M., Bockstahler, M., Fischer, A., Volz, C. H., Leib, C., Göser, S., Korkmaz-Icöz, S., Zittrich, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522288113 · Cited by 170
Fighting fire with fire: Poisonous Chinese herbal medicine for cancer therapy
Wang, S., Wu, X., Tan, M., Gong, J., Tan, W., Bian, B., Chen, M., & Wang, Y. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.041 · Cited by 165
High mobility group box 1 orchestrates tissue regeneration via CXCR4
Tirone, M., Tran, N. L., Ceriotti, C., Gorzanelli, A., Canepari, M., Bottinelli, R., Raucci, A., Maggio, S. D., Santiago, C. A., Mellado, M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160217 · Cited by 164
Huang, C.-Y., Chiang, S., Chen, W. T., Ke, T., Chen, T.-W., You, Y., Lin, C., Chao, K. S. C., & Huang, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1019-6 · Cited by 163
LncRNA MALAT1 induces colon cancer development by regulating miR‐129‐5p/HMGB1 axis
Wu, Q., Meng, W., Jie, Y., & Zhao, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26383 · Cited by 162
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
van Beijnum, J. R., Nowak-Sliwinska, P., van den Boezem, E., Hautvast, P., Buurman, W. A., & Griffioen, A. W. (2013) · Oncogene · doi:10.1038/onc.2012.49 · Cited by 159
Li, S., Huang, Y., Huang, Y., Fu, Y., Tang, D., Kang, R., Zhou, R., & Fan, X. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0519-z · Cited by 151
Self-citationWu, T., Zhang, W., Yang, G., Li, H., Chen, Q., Song, R., & Zhao, L. (2016) · Oncotarget · doi:10.18632/oncotarget.10413 · Cited by 142
Hamada, T., Torikai, M., Kuwazuru, A., Tanaka, M., Horai, N., Fukuda, T., Yamada, S., Nagayama, S., Hashiguchi, K., Sunahara, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23729 · Cited by 130
Quercetin Prevents LPS-Induced High-Mobility Group Box 1 Release and Proinflammatory Function
Tang, D., Kang, R., Xiao, W., Zhang, H., Lotze, M. T., Wang, H., & Xiao, X. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0119oc · Cited by 125
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
Yang, H., Wang, H., Levine, Y. A., Gunasekaran, M., Wang, Y., Addorisio, M. E., Zhu, S., Li, W., Li, J., de Kleijn, D. P. V., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85375 · Cited by 125
Self-citationMALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142–3p and miR-129–5p
Liu, K., Huang, J. X., Ni, J., Song, D., Ding, M., Wang, J., Huang, X., & Li, W. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1288324 · Cited by 125
HMGB1 induces angiogenesis in rheumatoid arthritis via HIF‐1α activation
Park, S. Y., Lee, S. W., Kim, H. Y., Lee, W. S., Hong, K. W., & Kim, C. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201444908 · Cited by 124
Schierbeck, H., Lundbäck, P., Palmblad, K., Klevenvall, L., Erlandsson-Harris, H., Andersson, U., & Ottosson, L. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00264 · Cited by 124
Chen, G., Li, J., Qiang, X., Czura, C. J., Ochani, M., Ochani, K., Ulloa, L., Yang, H., Tracey, K. J., Wang, P., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.c400018-jlr200 · Cited by 122
Self-citationZhang, X., Wheeler, D., Tang, Y. M., Guo, L., Shapiro, R. A., Ribar, T. J., Means, A. R., Billiar, T. R., Angus, D. C., & Rosengart, M. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5015 · Cited by 121
Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia
Hwang, J. S., Choi, H. S., Ham, S. A., Yoo, T., Lee, W. J., Paek, K. S., & Seo, H. G. (2015) · Scientific Reports · doi:10.1038/srep15971 · Cited by 118
Ma, C., Jiao, Y., Zhang, J., Yang, Q., Zhang, Z., Shen, Y., Chen, Z., & Zhao, Y. (2010) · Rheumatology International · doi:10.1007/s00296-010-1636-6 · Cited by 117
Maugeri, N., Franchini, S., Campana, L., Baldini, M., Ramirez, G. A., Sabbadini, M. G., Rovere, P. Q., & Manfredi, A. A. (2012) · Autoimmunity · doi:10.3109/08916934.2012.719946 · Cited by 114
Yoshizaki, A., Komura, K., Iwata, Y., Ogawa, F., Hara, T., Muroi, E., Takenaka, M., Shimizu, K., Hasegawa, M., Fujimoto, M., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9252-x · Cited by 113
The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines
Chen, R.-C., Yi, P.-P., Zhou, R.-R., Xiao, M.-F., Huang, Z.-B., Tang, D., Huang, Y., & Fan, X. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1978-6 · Cited by 111
Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis
Yang, M., Cao, L., Xie, M., Yu, Y., Kang, R., Yang, L., Zhao, M., & Tang, D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.013 · Cited by 110
Stevens, N. E., Chapman, M. J., Fraser, C. K., Kuchel, T. R., Hayball, J. D., & Diener, K. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-06205-z · Cited by 109
Wang, D., Liu, K., Wake, H., Teshigawara, K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/srep46243 · Cited by 106
Chen, M., Liu, Y., Varley, P. R., Chang, Y., He, X.-X., Huang, H., Tang, D., Lotze, M. T., Lin, J., & Tsung, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2147 · Cited by 95
Zhang, R., Jin, H., & Lou, F. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26021 · Cited by 89
DAMP-mediated autophagy contributes to drug resistance
Liu, L., Yang, M., Kang, R., Wang, Z., Zhao, Y., Yu, Y., Xie, M., Yin, X.-C., Livesey, K. M., Loze, M. T., et al. (2010) · Autophagy · doi:10.4161/auto.7.1.14005 · Cited by 86
Watanabe, T., Kubota, S., Nagaya, M., Ozaki, S., Nagafuchi, H., Akashi, K., Taira, Y., Tsukikawa, S., Oowada, S., & Nakano, S. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.10.019 · Cited by 86
Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy
Xue, J., Patergnani, S., Giorgi, C., Suarez, J. S., Goto, K., Bononi, A., Tanji, M., Novelli, F., Pastorino, S., Xu, R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007622117 · Cited by 86
Self-citationLiu, W., Zhang, Z., Zhang, Y., Chen, X., Guo, S., Yi, L., Xu, Y., Ji, C., Zhi-gang, B., & Wang, K. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1017691 · Cited by 81
Mesothelioma: recent highlights
Carbone, M., & Yang, H. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.29 · Cited by 79
Self-citationYe, C., Choi, J., Abraham, S., Wu, H., Diaz, D., Terreros, D. A., Shankar, P., & Manjunath, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216195109 · Cited by 76
Grégoire, M., Tadié, J., Uhel, F., Gacouin, A., Piau, C., Bone, N. B., Tulzo, Y. L., Abraham, E. H., Tarte, K., & Zmijewski, J. W. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5hi0316-128rr · Cited by 73
Kim, Y. M., Kim, H. J., & Chang, K. C. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.014 · Cited by 72
Qin, Y., Chen, Y., Wang, W., Wang, Z., Tang, G., Zhang, P., He, Z., Liu, Y., Dai, S.-M., & Shen, Q. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.48 · Cited by 70
Li, M., Song, L., Gao, X., Chang, W., & Qin, X. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.4.021 · Cited by 70
Sun, Y., Chen, H., Dai, J., Wan, Z., Xiong, P., Xu, Y. X., Han, Z., Chai, W., Gong, F., & Zheng, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01518 · Cited by 69
Enhanced HMGB1 Expression May Contribute to Th17 Cells Activation in Rheumatoid Arthritis
Shi, Y., Shotorbani, S. S., Su, Z., Liu, Y., Tong, J., Zheng, D., Chen, J., Liu, Y., Xu, Y., Jiao, Z., et al. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/295081 · Cited by 67
Cheng, P., Dai, W., Wang, F., Lu, J., Shen, M., Chen, K., Li, J., Zhang, Y., Wang, C., Yang, J., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.064 · Cited by 67
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
Pilzweger, C., & Holdenrieder, S. (2015) · Diagnostics · doi:10.3390/diagnostics5020219 · Cited by 67
Protective Effect of HMGB1 A Box on Organ Injury of Acute Pancreatitis in Mice
Yuan, H., Jin, X., Sun, J.-B., Li, F., Feng, Q., Zhang, W., Cao, Y., & Wang, Y. (2009) · Pancreas · doi:10.1097/mpa.0b013e31818166b4 · Cited by 61
Wu, H., & Zhou, C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.097 · Cited by 61
Östberg, T., Kawane, K., Nagata, S., Yang, H., Chavan, S. S., Klevenvall, L., Bianchi, M. E., Harris, H. E., Andersson, U., & Palmblad, K. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27590 · Cited by 58
Self-citationWang, S.-C., Chen, Y., Yu, X., Lu, Y., Wang, H., Wu, F., & Teng, L. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.12.024 · Cited by 58
The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer
Feng, A., Tu, Z., & Yin, B. (2016) · Oncotarget · doi:10.18632/oncotarget.7050 · Cited by 57
HMGB1 Mediates Anemia of Inflammation in Murine Sepsis Survivors
Valdés‐Ferrer, S. I., Papoin, J., Dancho, M. E., Olofsson, P. S., Li, J., Lipton, J. M. M., Avancena, P., Yang, H., Zou, Y.-R., Chavan, S. S., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00243 · Cited by 57
Self-citationHMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
Pellegrini, L., Xue, J., LARSON, D. L., Pastorino, S., Jube, S., Forest, K. H., Saad-Jube, Z., Napolitano, A., Pagano, I., Negi, V. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15152 · Cited by 57
Self-citationUzawa, A., Mori, M., Taniguchi, J., Masuda, S., Muto, M., & Kuwabara, S. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12036 · Cited by 53
Shin, J., Lee, H., Lee, H., Jin, Y., & Lee, J.-K. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.11.006 · Cited by 51
Maggio, S. D., Milano, G., Marchis, F. D., D’Ambrosio, A., Bertolotti, M., Palacios, B. S., Badi, I., Sommariva, E., Pompilio, G., Capogrossi, M. C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.012 · Cited by 50
Cottone, L., Capobianco, A., Gualteroni, C., Perrotta, C., Bianchi, M. E., Rovere, P. Q., & Manfredi, A. A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29125 · Cited by 49
Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment
Leo, F. D., Quilici, G., Tirone, M., Marchis, F. D., Mannella, V., Zucchelli, C., Preti, A., Gori, A., Casalgrandi, M., Mezzapelle, R., et al. (2019) · EMBO Reports · doi:10.15252/embr.201947788 · Cited by 49
Luan, Z.-G., Zhang, J., Yin, X.-H., Ma, X.-C., & Guo, R.-X. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12062 · Cited by 46
Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo
Jiang, W., Chen, M., Xiao, C., Yang, W., Qin, Q., Tan, Q., Liang, Z.-J., Liao, X., Mao, A., & Wei, C. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00818 · Cited by 46
Chandrasekaran, K. S., Sathyanarayanan, A., & Karunagaran, D. (2016) · Tumor Biology · doi:10.1007/s13277-016-5261-1 · Cited by 43
Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1
Shan, G., Tang, T., Xia, Y. Y., & Qian, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109248 · Cited by 43
MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1
Li, Y.-S., & Ce, Q. (2019) · Human Cell · doi:10.1007/s13577-019-00244-6 · Cited by 42
Yun, J., Jiang, G., Wang, Y., Xiao, T., Zhao, Y., Sun, D., Kaplan, H. J., & Shao, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00142 · Cited by 35
High‐Mobility Group Box 1 Inhibition Alleviates Lupus‐Like Disease in BXSB Mice
Zhang, C., Li, C., Jia, S., Yao, P.-B., Yang, Q., & Zhang, Y. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12165 · Cited by 32
MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1
Chen, J., & Li, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.059 · Cited by 31
miR‐505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1
Tian, L., Wang, Z., Hao, J., & Zhang, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28082 · Cited by 31
Tu, L., Long, X., Song, W., Lv, Z.-D., Zeng, H., Wang, T., Liu, X., Dong, J.-N., & Xu, P. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s206932 · Cited by 28
Pan, P., Cardinal, J. S., Dhupar, R., Rosengart, M. R., Lotze, M. T., Geller, D. A., Billiar, T. R., & Tsung, A. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1108713 · Cited by 27
Xiang, K., Cheng, L., Luo, Z., Ren, J., Tian, F., Tang, L., Chen, T., & Dai, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115982 · Cited by 23
Maugeri, N., Rovere, P. Q., & Manfredi, A. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00182 · Cited by 21
The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer
Li, P., Xu, M., Cai, H., Thapa, N., He, C., & Song, Z. (2019) · Bioscience Reports · doi:10.1042/bsr20181016 · Cited by 21
Wang, Z. P., Wang, X., Li, J., YANG, C., Xing, Z., CHEN, R., & Xu, F. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5340 · Cited by 18
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Zheng, J.-N., Li, Y., Yan, Y.-M., Yu, Y. Q., Shao, W., & Wang, Q. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02195-y · Cited by 18
Gao, E., Jiang, Y., Li, Z., Xue, D., & Zhang, W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6496 · Cited by 16
MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma
Yan, J., Ying, S., & Cai, X. (2018) · BioMed Research International · doi:10.1155/2018/2754941 · Cited by 16
Cited by
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 849
Inflammaging and Osteoarthritis
Motta, F., Barone, E., Sica, A., & Selmi, C. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08941-1 · Cited by 411
Emerging Roles of High-mobility Group Box-1 in Liver Disease
Wang, L., Dong, Z., Zhang, Y., & Peng, L. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00317 · Cited by 8
Metadata
- Authors
- Xue, J., Suarez, J. S., Minaai, M., Li, S., Gaudino, G., Pass, H. I., Carbone, M., & Yang, H.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2020-10-26
- Volume
- 236
- Issue
- 5
- Pages
- 3406-3419
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W3093868687
- Cited by
- 294
- References
- 117
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.